Syndex Bio Inc.
Syndex Bio introduces mcPCR, a novel and proprietary platform technology that preserves DNA methylation during DNA amplification, enabling simpler, faster, and more sensitive analysis of methylated DNA.
Funding history
About Syndex Bio Inc.
How much funding has Syndex Bio Inc. raised?
Syndex Bio Inc. has raised $15.5M in total funding. The most recent round was Series B.
Where is Syndex Bio Inc. headquartered?
Syndex Bio Inc. is headquartered in Santa Monica, CA.
What does Syndex Bio Inc. do?
Syndex Bio introduces mcPCR, a novel and proprietary platform technology that preserves DNA methylation during DNA amplification, enabling simpler, faster, and more sensitive analysis of methylated DNA.
What makes Syndex Bio Inc. notable?
Syndex Bio was founded by Geoff Smith and raised a $15.5M seed round backed by ARCH Venture Partners, one of the top-tier biotech venture firms.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
